CD8A and cancer: Thus, combining the massive increase in CPI therapy with the growth in adoptive NK cell therapeutics indicates that there is now a great potential to generate novel therapeutic combinations that target both CD8 T cells, NK cells and Tregs generating a holistic approach to cancer immunotherapy.